Kaizen Advisory’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Kaizen Advisory's ELV Position: Q4 2018 in Review
Kaizen Advisory increased its Elevance Health (ELV) stake by 15% in Q4 2018, buying an estimated $24.7K and bringing the position to 688 shares worth $181K. The position accounts for 0.13% of the portfolio, ranked #168.
Kaizen Advisory first reported a position in ELV in Q4 2017 and has held it in 5 quarters since. 997 funds tracked by Wall St. Rank hold ELV as of Q4 2018.
- Kaizen Advisory held 688 shares of Elevance Health worth $181K as of Q4 2018.
- Kaizen Advisory bought 90 Elevance Health shares in Q4 2018, an estimated $24.7K.
- Elevance Health made up 0.13% of Kaizen Advisory's portfolio in Q4 2018, its #168 holding.
- Kaizen Advisory first reported a position in Elevance Health in Q4 2017 and has held it in 5 quarters since.
- 997 funds tracked by Wall St. Rank held Elevance Health as of Q4 2018.
Based on Kaizen Advisory's 13F filing for Q4 2018, filed 15 Feb 2019.